Skip to content
PubMed This is a summary of 87 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 87 referenced papers

Top Authors

Y. Ville
Hôpital Necker-Enfants Malades
Raymund R. Razonable
Mayo Clinic in Arizona
Mark R. Schleiss
University of Minnesota Medical Center
Ajit P. Limaye
University of California, San Francisco
Michael Boeckh
University of Washington
Paul Griffiths
The Royal Free Hospital
Marianne Leruez‐Ville
Hôpital Necker-Enfants Malades
Suresh B. Boppana
University of Alabama at Birmingham
Per Ljungman
Karolinska University Hospital
William J. Britt
University of Alabama at Birmingham

Top Institutions

Ranked by publications Top 10 institutions
02

Merck & Co., Inc., Rahway, NJ, USA (United States)

Rahway, United States

34 papers
08

The University of Texas MD Anderson Cancer Center

Houston, United States

31 papers

References

References (87)
  1. 1

    Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait.

    Madi N, Al-Qaser M, Edan R, Al-Nakib W

    Transplantation proceedings 2015; (47(6)):1802-7.

    PMID: 26293054
  2. 2

    Retrospective study of cytomegalovirus retinitis complicated with acquired immunodeficiency syndrome.

    Huang G, Jiang Q, Li M, et al.

    International journal of clinical and experimental medicine 2015; (8(6)):9537-42.

    PMID: 26309620
  3. 3

    Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.

    Nishijima T, Yashiro S, Teruya K, et al.

    PloS one 2015; (10(9)):e0136747 doi:10.1371/journal.pone.0136747.

    PMID: 26375282
  4. 4

    Diagnosis and antenatal management of congenital cytomegalovirus infection.

    , Hughes BL, Gyamfi-Bannerman C

    American journal of obstetrics and gynecology 2016; (214(6)):B5-B11.

    PMID: 26902990
  5. 5

    Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.

    Fisher CE, Alexander J, Bhattacharya R, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2016; (18(3)):372-80 doi:10.1111/tid.12531.

    PMID: 27004439
  6. 6

    A case report of small bowel perforation secondary to cytomegalovirus related immune reconstitution inflammatory syndrome in an AIDS patient.

    Gutiérrez-Delgado EM, Villanueva-Lozano H, García Rojas-Acosta MJ, et al.

    Annals of medicine and surgery (2012) 2017; (13()):20-23 doi:10.1016/j.amsu.2016.11.001.

    PMID: 28018589
  7. 7

    Cytomegalovirus, Macrophages and Breast Cancer.

    Pasquereau S, Al Moussawi F, Karam W, et al.

    The open virology journal 2017; (11()):15-27 doi:10.2174/1874357901711010015.

    PMID: 28567162
  8. 8

    Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks' threshold.

    Enders M, Daiminger A, Exler S, Enders G

    Prenatal diagnosis 2017; (37(9)):940-942 doi:10.1002/pd.5107.

    PMID: 28677115
  9. 9

    Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study.

    Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, et al.

    Developmental medicine and child neurology 2017; (59(12)):1261-1268 doi:10.1111/dmcn.13556.

    PMID: 28990181
  10. 10

    Insight Into Long-term Neurodevelopmental Outcomes in Asymptomatic Congenital CMV Infection.

    Boppana SB, Fowler KB

    Pediatrics 2017; (140(5)) doi:10.1542/peds.2017-2526.

    PMID: 29066579
  11. 11

    Impact of electronic health record-based, pharmacist-driven valganciclovir dose optimization in solid organ transplant recipients.

    Hensler D, Richardson CL, Brown J, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2018; (20(2)):e12849 doi:10.1111/tid.12849.

    PMID: 29360250
  12. 12

    Immune Monitoring for CMV in Transplantation.

    Yong MK, Lewin SR, Manuel O

    Current infectious disease reports 2018; (20(4)):4 doi:10.1007/s11908-018-0610-4.

    PMID: 29542023
  13. 13

    Hematologic Adverse Events Associated With Prolonged Valganciclovir Treatment in Congenital Cytomegalovirus Infection.

    Ziv L, Yacobovich J, Pardo J, et al.

    The Pediatric infectious disease journal 2019; (38(2)):127-130 doi:10.1097/INF.0000000000002079.

    PMID: 29677086
  14. 14

    Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.

    Meesing A, Razonable RR

    Expert review of clinical pharmacology 2018; (11(8)):773-788 doi:10.1080/17512433.2018.1501557.

    PMID: 30009675
  15. 15

    Usefulness of a flow chart for targeted screening of congenital cytomegalovirus-related hearing loss.

    Ciccia M, Monari C, Vitagliano G, et al.

    Journal of neonatal-perinatal medicine 2018; (11(3)):339-343 doi:10.3233/NPM-17110.

    PMID: 30040746
  16. 16

    Active cytomegalovirus retinitis after the start of antiretroviral therapy.

    Heiden D, Tun N, Smithuis FN, et al.

    The British journal of ophthalmology 2019; (103(2)):157-160 doi:10.1136/bjophthalmol-2018-312406.

    PMID: 30196272
  17. 17

    EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.

    Sohn MJ, Cho JM, Moon JS, et al.

    Medicine 2018; (97(38)):e12380 doi:10.1097/MD.0000000000012380.

    PMID: 30235701
  18. 18

    Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection.

    Tanimura K, Yamada H

    International journal of molecular sciences 2018; (19(12)) doi:10.3390/ijms19123760.

    PMID: 30486359
  19. 19

    Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy.

    Faure-Bardon V, Magny JF, Parodi M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (69(9)):1526-1532 doi:10.1093/cid/ciy1128.

    PMID: 30596974
  20. 20

    Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts".

    Mercorelli B, Luganini A, Palù G, et al.

    Viruses 2019; (11(2)) doi:10.3390/v11020117.

    PMID: 30699923
  21. 21

    Routine Immediate Eye Examination at the Point of Care for Diagnosis of AIDS-Related Cytomegalovirus Retinitis Among Patients With a CD4 Count <100 in Myanmar.

    Ei WLSS, Pyar Soe K, Hilbig A, et al.

    Open forum infectious diseases 2019; (6(7)):ofz280 doi:10.1093/ofid/ofz280.

    PMID: 31304189
  22. 22

    Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.

    Girmenia C, Lazzarotto T, Bonifazi F, et al.

    Clinical transplantation 2019; (33(10)):e13666 doi:10.1111/ctr.13666.

    PMID: 31310687
  23. 23

    Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study.

    Ocieczek P, Barnacle JR, Gumulira J, et al.

    Open forum infectious diseases 2019; (6(11)):ofz439 doi:10.1093/ofid/ofz439.

    PMID: 31723570
  24. 24

    Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.

    Dorfman L, Amir J, Attias J, Bilavsky E

    European journal of pediatrics 2020; (179(5)):807-812 doi:10.1007/s00431-019-03558-7.

    PMID: 31927626
  25. 25

    Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients.

    Imlay H, Dumitriu Carcoana AO, Fisher CE, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2020; (22(3)):e13255 doi:10.1111/tid.13255.

    PMID: 32020736
  26. 26

    [Neurological sequelae in patients with congenital cytomegalovirus].

    de Juan Gallach A, Alemany Albert M, Marco Hernández AV, et al.

    Anales de pediatria 2020; (93(2)):111-117 doi:10.1016/j.anpedi.2019.12.021.

    PMID: 32111550
  27. 27

    Outcome and management of newborns with congenital cytomegalovirus infection.

    Nicloux M, Peterman L, Parodi M, Magny JF

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2020; (27(3)):160-165 doi:10.1016/j.arcped.2020.01.006.

    PMID: 32127242
  28. 28

    Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.

    Singh N, Winston DJ, Razonable RR, et al.

    JAMA 2020; (323(14)):1378-1387 doi:10.1001/jama.2020.3138.

    PMID: 32286644
  29. 29

    Pathophysiology of Hyperechogenic Bowel in Congenitally Human Cytomegalovirus Infected Fetuses.

    Gabrielli L, Bonasoni MP, Chiereghin A, et al.

    Microorganisms 2020; (8(5)) doi:10.3390/microorganisms8050779.

    PMID: 32455864
  30. 30

    Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study.

    Périllaud-Dubois C, Bouthry E, Jadoui A, et al.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2020; (132()):104641 doi:10.1016/j.jcv.2020.104641.

    PMID: 32947202
  31. 31

    Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real-world evidence.

    Raval AD, Kistler KD, Tang Y, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2021; (23(2)):e13483 doi:10.1111/tid.13483.

    PMID: 33012092
  32. 32

    Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment.

    Chiopris G, Veronese P, Cusenza F, et al.

    Microorganisms 2020; (8(10)) doi:10.3390/microorganisms8101516.

    PMID: 33019752
  33. 33

    Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

    Demmler-Harrison GJ, Miller JA,

    PloS one 2020; (15(10)):e0240172 doi:10.1371/journal.pone.0240172.

    PMID: 33035237
  34. 34

    Regulation of the MIE Locus During HCMV Latency and Reactivation.

    Dooley AL, O'Connor CM

    Pathogens (Basel, Switzerland) 2020; (9(11)) doi:10.3390/pathogens9110869.

    PMID: 33113934
  35. 35

    Cytomegalovirus infection in pregnancy - An update.

    Navti OB, Al-Belushi M, Konje JC,

    European journal of obstetrics, gynecology, and reproductive biology 2021; (258()):216-222 doi:10.1016/j.ejogrb.2020.12.006.

    PMID: 33454510
  36. 36

    Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia.

    Rico A, Dollard SC, Valencia D, et al.

    Journal of medical virology 2021; (93(11)):6393-6397 doi:10.1002/jmv.26815.

    PMID: 33475162
  37. 37

    Sensitivity of Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus Infection.

    Dollard SC, Dreon M, Hernandez-Alvarado N, et al.

    JAMA pediatrics 2021; (175(3)):e205441 doi:10.1001/jamapediatrics.2020.5441.

    PMID: 33523119
  38. 38

    The burden of cytomegalovirus infection remains high in high-risk kidney transplant recipients despite six-month valganciclovir prophylaxis.

    Räihä J, Ortiz F, Mannonen L, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2021; (23(4)):e13577 doi:10.1111/tid.13577.

    PMID: 33527660
  39. 39

    Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation Recipients.

    Loy V

    Clinical liver disease 2021; (17(2)):53-56 doi:10.1002/cld.962.

    PMID: 33680435
  40. 40

    Brain MRI findings in newborns with congenital cytomegalovirus infection: results from a large cohort study.

    Vande Walle C, Keymeulen A, Schiettecatte E, et al.

    European radiology 2021; (31(10)):8001-8010 doi:10.1007/s00330-021-07776-2.

    PMID: 33787973
  41. 41

    Cytomegalovirus-A Risk Factor for Childhood Hearing Loss: A Systematic Review.

    Vos B, Noll D, Whittingham J, et al.

    Ear and hearing 2021; (42(6)):1447-1461 doi:10.1097/AUD.0000000000001055.

    PMID: 33928914
  42. 42

    Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.

    Ross SA, Kimberlin D

    Antiviral research 2021; (191()):105083 doi:10.1016/j.antiviral.2021.105083.

    PMID: 33964331
  43. 43

    A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells.

    Poole E, Carlan da Silva MC, Huang C, et al.

    mBio 2021; (12(3)):e0022721 doi:10.1128/mBio.00227-21.

    PMID: 34061599
  44. 44

    Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.

    Adane T, Getawa S

    The Journal of international medical research 2021; (49(8)):3000605211034656 doi:10.1177/03000605211034656.

    PMID: 34382466
  45. 45

    Renal toxicity of high-dosage valacyclovir for secondary prevention of congenital cytomegalovirus infection: a dose regimen-related issue.

    Ville Y, Leruez-Ville M

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2021; (58(4)):637-638 doi:10.1002/uog.24753.

    PMID: 34468055
  46. 46

    Congenital Cytomegalovirus and Hepatic Failure: An Underrecognized Complication.

    Souder JP, Grimm E, Pinninti S, et al.

    The Pediatric infectious disease journal 2022; (41(2)):e49-e53 doi:10.1097/INF.0000000000003381.

    PMID: 34694253
  47. 47

    Amniocentesis to diagnose congenital cytomegalovirus infection following maternal primary infection.

    Dinsmoor MJ, Fette LM, Hughes BL, et al.

    American journal of obstetrics & gynecology MFM 2022; (4(4)):100641 doi:10.1016/j.ajogmf.2022.100641.

    PMID: 35526782
  48. 48

    Congenital cytomegalovirus infection with brainstem hemorrhage and polymicrogyria: Necropsic and histopathological findings.

    Arredondo Montero J, Bronte Anaut M, Caballero Martínez MC, et al.

    Congenital anomalies 2022; (62(6)):248-253 doi:10.1111/cga.12488.

    PMID: 35941838
  49. 49

    Congenital cytomegalovirus infection diagnostics and management.

    Pinninti S, Boppana S

    Current opinion in infectious diseases 2022; (35(5)):436-441 doi:10.1097/QCO.0000000000000874.

    PMID: 35984001
  50. 50

    Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations.

    Kleiboeker HL, Descourouez JL, Schulz LT, et al.

    The Annals of pharmacotherapy 2023; (57(5)):597-608 doi:10.1177/10600280221118959.

    PMID: 36003036
  51. 51

    High Monocyte Count Associated with Human Cytomegalovirus Replication In Vivo and Glucocorticoid Therapy May Be a Hallmark of Disease.

    Zdziarski P, Gamian A

    International journal of molecular sciences 2022; (23(17)) doi:10.3390/ijms23179595.

    PMID: 36076989
  52. 52

    Emergency gastrointestinal tract operation associated with cytomegalovirus infection.

    Kim S, Yoon KW, Gil E, et al.

    Annals of surgical treatment and research 2023; (104(2)):119-125 doi:10.4174/astr.2023.104.2.119.

    PMID: 36816733
  53. 53

    Rethinking human cytomegalovirus latency reservoir.

    Schwartz M, Stern-Ginossar N

    Annals of the New York Academy of Sciences 2023; (1524(1)):30-36 doi:10.1111/nyas.14994.

    PMID: 37026581
  54. 54

    Congenital Cytomegalovirus Infection Screening in Newborns From Saliva Samples by Real-Time Polymerase Chain Reaction Analysis.

    Günlemez A, Kolaylı F, Yazıcı Özçelik E, et al.

    Turkish archives of pediatrics 2023; (58(4)):371-375 doi:10.5152/TurkArchPediatr.2023.22309.

    PMID: 37357451
  55. 55

    Counseling in fetal medicine: Congenital cytomegalovirus infection.

    D'Alberti E, Rizzo G, Khalil A, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (295()):8-17 doi:10.1016/j.ejogrb.2024.01.037.

    PMID: 38310675
  56. 56

    CMV-induced Hearing Loss.

    Singh S, Maheshwari A, Boppana S

    Newborn (Clarksville, Md.) 2023; (2(4)):249-262 doi:10.5005/jp-journals-11002-0081.

    PMID: 38348106
  57. 57

    Fetal Cytomegalovirus Infection in the Absence of Maternal Cytomegalovirus-IgM Seropositivity.

    Erenel H, Tuna G, Alpay V, Polat İ

    Reproductive sciences (Thousand Oaks, Calif.) 2024; (31(6)):1533-1540 doi:10.1007/s43032-024-01487-x.

    PMID: 38388923
  58. 58

    Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients.

    Valencia Deray KG, Danziger-Isakov LA, Downes KJ

    Journal of the Pediatric Infectious Diseases Society 2024; (13(Supplement_1)):S14-S21 doi:10.1093/jpids/piad059.

    PMID: 38417084
  59. 59

    Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada.

    Dana Flanders W, Lally C, Dilley A, Diaz-Decaro J

    Journal of medical virology 2024; (96(3)):e29525 doi:10.1002/jmv.29525.

    PMID: 38529529
  60. 60

    Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques.

    Sadowska-Klasa A, Özkök S, Xie H, et al.

    Blood advances 2024; (8(14)):3639-3651 doi:10.1182/bloodadvances.2023012175.

    PMID: 38537062
  61. 61

    Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases.

    Hsieh CR, Wu RC, Kuo CJ, et al.

    BMC infectious diseases 2024; (24(1)):443 doi:10.1186/s12879-024-09317-w.

    PMID: 38671346
  62. 62

    From diagnosis to management: current perspectives on congenital cytomegalovirus infection.

    Buchfellner M, Ross S

    Current opinion in infectious diseases 2024; (37(4)):232-237 doi:10.1097/QCO.0000000000001023.

    PMID: 38748563
  63. 63

    Cytomegalovirus (CMV) Polyradiculopathy: An Important "AIDS-Defining" Illness Complication.

    Finessi A, Aziz MA, Izquierdo-Pretel G, Bracho A

    Cureus 2024; (16(4)):e58230 doi:10.7759/cureus.58230.

    PMID: 38752099
  64. 64

    Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis.

    Arvanitis P, Davis MR, Farmakiotis D

    Transplantation reviews (Orlando, Fla.) 2024; (38(4)):100860 doi:10.1016/j.trre.2024.100860.

    PMID: 38815340
  65. 65

    Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy.

    Lin RY, Anderson AD, Natori Y, et al.

    Blood advances 2024; (8(14)):3813-3822 doi:10.1182/bloodadvances.2024012922.

    PMID: 38838226
  66. 66

    Immune recovery uveitis: an ocular manifestation in HIV/AIDS receiving treatment.

    Dionson MM

    Current opinion in ophthalmology 2024; (35(6)):507-512 doi:10.1097/ICU.0000000000001078.

    PMID: 39046420
  67. 67

    Human cytomegalovirus and neonatal infection.

    Lawrence SM

    Current research in microbial sciences 2024; (7()):100257 doi:10.1016/j.crmicr.2024.100257.

    PMID: 39070527
  68. 68

    High seroprevalence of CMV among Algerian hemodialysis patients and the general population: Intermediate-risk patients for post-transplant CMV infection.

    Lamara Mahammed L, Omrani Z, Bellachia N, et al.

    Transplant immunology 2025; (88()):102168 doi:10.1016/j.trim.2024.102168.

    PMID: 39716649
  69. 69

    Ultrasound features of congenital cytomegalovirus infection in the first trimester: A case report.

    Chen XL, Zhang LQ, Bai LL

    World journal of clinical cases 2025; (13(5)):97629 doi:10.12998/wjcc.v13.i5.97629.

    PMID: 39959771
  70. 70

    Investigation of the infection route of HIV-associated cytomegalovirus retinitis.

    Cai J, Xie ZK, Tang DY, et al.

    International journal of ophthalmology 2025; (18(3)):478-486 doi:10.18240/ijo.2025.03.15.

    PMID: 40103955
  71. 71

    Deciphering Positive Cytomegalovirus Immunoglobulin M Test Results in Immunocompetent Adults Hospitalized With Illness Suspicious for Acute Cytomegalovirus Infection: A Multihospital Study.

    Samuel S, Thomas S, Asleson L, et al.

    Open forum infectious diseases 2025; (12(3)):ofaf144 doi:10.1093/ofid/ofaf144.

    PMID: 40134634
  72. 72

    Neuron-restricted cytomegalovirus latency in the central nervous system regulated by CD4+ T-cells and IFN-γ.

    Krstanović F, Mihalić A, Rashidi AS, et al.

    Journal of neuroinflammation 2025; (22(1)):95 doi:10.1186/s12974-025-03422-6.

    PMID: 40158177
  73. 73

    [Secondary Prevention of Fetal Cytomegalovirus Infection Through Valacyclovir Administration in Maternal Primary Infections During the Periconceptional Period and First Trimester of Pregnancy].

    Chatzakis C, Bourgon N, Leruez-Ville M, Ville Y

    Gynecologie, obstetrique, fertilite & senologie 2025; (53(7-8)):341-348 doi:10.1016/j.gofs.2025.03.010.

    PMID: 40185476
  74. 74

    Congenital cytomegalovirus retinitis of prematurity: a case report and literature review.

    Li Y, Sun W, Jin X, et al.

    Frontiers in pediatrics 2025; (13()):1558820 doi:10.3389/fped.2025.1558820.

    PMID: 40248023
  75. 75

    CMV retinitis in HIV-infected patients: Plasma viral load utility in diagnosis.

    Benadda S, Achour N, Ziane H, Kezzal K

    Diagnostic microbiology and infectious disease 2025; (113(2)):116926 doi:10.1016/j.diagmicrobio.2025.116926.

    PMID: 40446649
  76. 76

    Human Cytomegalovirus UL78 is a Nuclear-Localized GPCR Necessary for Efficient Reactivation from Latent Infection in CD34+ Hematopoietic Progenitor Cells.

    Medica S, Diggins NL, Denton M, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.06.02.657350.

    PMID: 40501644
  77. 77

    Estimating Risks of Central Nervous System Disturbance Associated with Medications for Herpes Zoster: Findings from a Regional Population-Based Cohort Study Using the Shizuoka Kokuho Database.

    Hagiwara R, Nakatani E, Kaneda H, et al.

    Drugs - real world outcomes 2025; (12(3)):399-410 doi:10.1007/s40801-025-00500-2.

    PMID: 40522612
  78. 78

    The impact of recent Covid-19 infection on cytomegalovirus antibodies.

    Dan W, Yuzhu X, Han W, et al.

    Journal of infection and public health 2025; (18(10)):102848 doi:10.1016/j.jiph.2025.102848.

    PMID: 40614677
  79. 79

    Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients.

    Duret A, Charles O, Margetts BK, et al.

    British journal of haematology 2025; (207(3)):911-919 doi:10.1111/bjh.20254.

    PMID: 40630011
  80. 80

    Vestibular Dysfunction in Pediatric Patients With Congenital Cytomegalovirus Infection and Hearing Loss: Occurrence and Characteristics.

    Zhou G, Peterson H, Yun A, Brodsky J

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2025; (46(9)):1124-1128 doi:10.1097/MAO.0000000000004600.

    PMID: 40690203
  81. 81

    Changes in Neutrophil Count During Valganciclovir Therapy for Symptomatic Congenital Cytomegalovirus Infection.

    Kawamura A, Abe S, Shirai K, et al.

    Biomedicines 2025; (13(7)) doi:10.3390/biomedicines13071739.

    PMID: 40722810
  82. 82

    Letermovir and Tacrolimus Drug-Drug Interaction in a Pediatric Kidney Transplant Patient: A Case Report and Review of the Literature.

    Berger I, Matsuda-Abedini M, Haubrich K

    Pediatric transplantation 2025; (29(6)):e70143 doi:10.1111/petr.70143.

    PMID: 40747771
  83. 83

    Diagnostic Performance of Salivary PCR for the Detection of Congenital Cytomegalovirus: A Systematic Review and Meta-Analysis.

    Rady SMA, Abdelmoati MI, Sabra S, et al.

    Viruses 2025; (17(9)) doi:10.3390/v17091253.

    PMID: 41012680
  84. 84

    Utility of cytomegalovirus (CMV) qualitative polymerase chain reaction from gastrointestinal biopsies in diagnosis of CMV gastrointestinal disease: A 10-year retrospective study.

    Schonhofer C, Lo CK, Owen DR, et al.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2025; (181()):105879 doi:10.1016/j.jcv.2025.105879.

    PMID: 41086543
  85. 85

    The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection.

    Chatzakis C, Bourgon N, Fourgeaud J, et al.

    Best practice & research. Clinical obstetrics & gynaecology 2025; (103()):102679 doi:10.1016/j.bpobgyn.2025.102679.

    PMID: 41175678
  86. 86

    Associations Between Fetal Symptoms During Pregnancy and Neonatal Clinical Complications with Cytomegalovirus Infection.

    Bartek V, Csire M, Kiss G, et al.

    Children (Basel, Switzerland) 2025; (12(12)) doi:10.3390/children12121690.

    PMID: 41462830
  87. 87

    Prevalence and Risk Factors for Cytomegalovirus Retinitis Among People Living with HIV in Sub-Saharan Africa in the Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis.

    Ismail MF, Khalafalla I, Sheck ZO, et al.

    Scientific reports 2026; (16(1)).

    PMID: 42209549